Sec Form 4 Filing - Dudum Andrew @ Hims & Hers Health, Inc. - 2021-03-29

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Dudum Andrew 2. Issuer Name and Ticker or Trading Symbol Hims & Hers Health, Inc. [ HIMS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) 2269 CHESTNUT STREET, #523 3. Date of Earliest Transaction (MM/DD/YY) 03/29/2021 (Street) SAN FRANCISCO, CA94123 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Restricted Stock Unit ( 1 ) 03/29/2021 A 158,769 ( 1 ) ( 1 ) Class A Common Stock 158,769 $ 0 158,769 D Restricted Stock Unit ( 1 ) 03/29/2021 A 3,159 ( 1 ) ( 1 ) Class A Common Stock 3,159 $ 0 3,159 D Restricted Stock Unit ( 2 ) 03/29/2021 A 317,539 ( 2 ) ( 2 ) Class A Common Stock 317,539 $ 0 317,539 D Restricted Stock Unit ( 2 ) 03/29/2021 A 6,319 ( 2 ) ( 2 ) Class A Common Stock 6,319 $ 0 6,319 D Restricted Stock Unit ( 3 ) 03/29/2021 A 158,769 ( 3 ) ( 3 ) Class A Common Stock 158,769 $ 0 158,769 D Restricted Stock Unit ( 3 ) 03/29/2021 A 3,159 ( 3 ) ( 3 ) Class A Common Stock 3,159 $ 0 3,159 D Restricted Stock Unit ( 4 ) 03/29/2021 A 57,205 ( 4 ) ( 4 ) Class A Common Stock 57,205 $ 0 57,205 D Restricted Stock Unit ( 4 ) 03/29/2021 A 1,707 ( 4 ) ( 4 ) Class A Common Stock 1,707 $ 0 1,707 D Restricted Stock Unit ( 4 ) 03/29/2021 A 117,279 ( 4 ) ( 4 ) Class A Common Stock 117,279 $ 0 117,279 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Dudum Andrew 2269 CHESTNUT STREET, #523 SAN FRANCISCO, CA94123 X X Chief Executive Officer Signatures /s/ Soleil Boughton - Attorney-in-Fact 03/31/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on the specified dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. ( 2 )The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vested upon grant. ( 3 )The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs fully vest when (i) the issuer is acquired and the per share consideration is equal to at least $38.31 per share (subject to appropriate adjustment for stock splits and otherwise, the "Threshold Amount") or (ii) the per share closing trading price of the issuer's Class A Common Stock is at least equal to the Threshold Amount (the date on which such closing trading price is achieved, the "Achievement Date"), provided that the Reporting Person remains in continuous service as chief executive officer or a director through such acquisition or the Achievement Date, as applicable. ( 4 )The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.